Clinical Trials
6 trialsNCT06940570 2025-10-23
MATCH
University of Texas Southwestern Medical Center
Phase 3 Suspended
NCT05325164 2022-12-05
METHADOPT
Ottawa Hospital Research Institute
Phase 3 Withdrawn
NCT00505414 2019-11-01
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Terminated
NCT01675622 2018-05-21
Immediate-Release Oxycodone Capsules Study in Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT00201539 2015-04-08
Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients
Norwegian University of Science and Technology
Phase 3 Completed
NCT01309386 2013-03-13
A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants
Janssen Pharmaceutical K.K.
Phase 3 Completed